Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for ËÄÉ«AV's Generics Business Unit, discusses what makes ËÄÉ«AV unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jan 01, 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Read more
Scientific Article
Scientific Article
/ Jan 01, 1995
Aspects of the stereospecific hydrogenation of the exocyclic double-bond of methacycline
Read more
Scientific Article